P&G’s (PG) $3.8B Wellness Deal Collides With a Costly Outlook

Bull Case: A Bigger Foothold In Trusted Wellness

The Thorne acquisition gives Procter & Gamble introduction into a class built connected objective credibility alternatively than support space. Thorne has spent 40 years gathering relationships with healthcare practitioners, and L Catterton's announcement noted the institution developed a proprietary AI wellness advisor to assistance consumers navigate its supplement lineup, a instrumentality practitioners tin constituent their patients to directly.

The transaction is expected to adjacent successful the 4th fourth of 2026, an all-cash woody with nary indebtedness oregon equity swapped into the mix. Procter & Gamble isn't skimping connected shareholders portion it shops, either. The institution returned $10.2 cardinal successful dividends and $5.0 cardinal successful stock repurchases during fiscal 2026, and it plans astir the aforesaid combination, astir $10 cardinal successful dividends and $5 cardinal successful buybacks, for fiscal 2027. There's a lawsuit buried wrong the company's ain guidance, too. Strip retired the astir $1 cardinal successful commodity, energy, and proscription costs absorption expects to sorb adjacent year, and halfway EPS would beryllium increasing astatine astir 10% alternatively of the 0% to 3% baked into the outlook.

Bear Case: Guidance That Undercuts The Story

The numbers down the fiscal 2027 outlook explicate the caution. Management guided halfway EPS to $6.89 to $7.11, implying maturation of conscionable 0% to 3%, and pointed to astir $1 cardinal successful after-tax commodity, energy, and proscription costs arsenic the main culprit. Add higher nett involvement expense, little non-operating income, and unfavorable currency, and the full resistance reaches $0.56 per share, wiping retired astir 8 percent points of halfway net maturation earlier the twelvemonth adjacent starts.

The inclination already shows up successful caller results. In the fiscal 4th quarter, nett income roseate 2% year-over-year to $21.2 cardinal portion integrated income were flat, and halfway EPS fell 3% to $1.43. For the afloat fiscal year, nett income grew 3% to $87.0 billion, but integrated income roseate lone 1%, and each spot of that maturation came from higher prices alternatively than much units sold. Volume and premix didn't move. Shares commercialized adjacent $144, astir 5% supra their 52-week debased of $137.62, oregon astir 21 times fiscal 2026 halfway net of $6.89. That's not an costly multiple, but it isn't inexpensive for a concern guiding to low-single-digit growth.